User profiles for "author:Vera Golder"
 | Vera GolderMonash University Verified email at monash.edu Cited by 1180 |
Ankylosing spondylitis: an update
V Golder, L Schachna - Australian family physician, 2013 - search.informit.org
Background: Ankylosing spondylitis (AS) affects one in 200 individuals and is usually
diagnosed many years after onset of symptoms. Chronic back pain is common and …
diagnosed many years after onset of symptoms. Chronic back pain is common and …
Treatment targets in SLE: remission and low disease activity state
V Golder, MWP Tsang-A-Sjoe - Rheumatology, 2020 - academic.oup.com
Treat-to-target strategies have changed the approach to management of many chronic
conditions, with improvements in patient outcomes. The key to success of treat to target is …
conditions, with improvements in patient outcomes. The key to success of treat to target is …
[HTML][HTML] Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international Taskforce
Systemic lupus erythematosus (SLE) is a disease of high unmet therapeutic need. The
challenge of accurately measuring clinically meaningful responses to treatment has …
challenge of accurately measuring clinically meaningful responses to treatment has …
[HTML][HTML] Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study
Background Systemic lupus erythematosus (SLE) is associated with significant impairment
of health-related quality of life (HR-QoL). Recently, meeting a definition of a lupus low …
of health-related quality of life (HR-QoL). Recently, meeting a definition of a lupus low …
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
Background Treat-to-target strategies have improved outcomes in single-organ diseases
with simple clinical or laboratory endpoints. A lack of validated endpoints has prevented …
with simple clinical or laboratory endpoints. A lack of validated endpoints has prevented …
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort …
R Kandane-Rathnayake, V Golder… - The Lancet …, 2022 - thelancet.com
Background Treat-to-target goals for patients with systemic lupus erythematosus (SLE) have
been validated to protect against organ damage and to improve quality of life. We aimed to …
been validated to protect against organ damage and to improve quality of life. We aimed to …
[HTML][HTML] 'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study
R Kandane-Rathnayake, W Louthrenoo, A Hoi… - Arthritis Research & …, 2022 - Springer
Background The unmet need in systemic lupus erythematosus (SLE) with the current
standard of care is widely recognised, but few studies have quantified this. The recent …
standard of care is widely recognised, but few studies have quantified this. The recent …
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
Objective We evaluated the discriminant capacity of the Lupus Low Disease Activity State
(LLDAS) in post-hoc analysis of data from the BLISS-52 and BLISS-76 trials of belimumab in …
(LLDAS) in post-hoc analysis of data from the BLISS-52 and BLISS-76 trials of belimumab in …
Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic
Objective Systemic lupus erythematosus (SLE), an autoimmune condition with diverse
clinical manifestations, is reported to have different expression in populations of different …
clinical manifestations, is reported to have different expression in populations of different …
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
Objectives In patients with systemic lupus erythematosus (SLE), lupus low disease activity
state (LLDAS) attainment is associated with improved outcomes. We investigated LLDAS …
state (LLDAS) attainment is associated with improved outcomes. We investigated LLDAS …